Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pralatrexate Combined With Chidamide Bridging Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed Peripheral T-cell Lymphoma

NCT06671717 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06671717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06671717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pralatrexate Combined With Chidamide Bridging Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed Peripheral T-cell Lymphoma
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2024
Completion date
July 31, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory peripheral t-cell lymphoma, relapsed peripheral t-cell lymphoma